BMPR2 and breast carcinoma: Genetic alterations in BMPR1A, BMPR1B, or BMPR2 were found in around 6, 7, or 5% of patients with breast cancer, respectively, with the major form of genetic alternation being an upregulation of mRNA encoding BMP receptors (data not shown).